GEN Exclusives

More »

Systems Biology - Related Content

  • Page 1 of 1 (2 items) 1 
  • GEN Podcasts
  • A SYSTEMS BIOLOGY VIEW OF CANCER
    - Interview with Reinhard Laubenbacher, Ph.D., Professor, Virginia Bioinformatics Institute, Professor, Department of Mathematics, Virginia Tech, and Adjunct Professor, Department of Cancer Biology, Wake Forest University
  • miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY
    - Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology
  • Page 1 of 1 (2 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?